RE: Broker Report21 Aug 2024 07:08
It’s already out
at this price. We believe the market is unfairly valuing Henkries as an early-stage project, rather
than at an advanced late stage, which could be within 24-months of production. To this end, we recommend the shares as a 'Buy' with a price target of 3.33p per share, an increase of 51% from our previous 2.2p valuation, which therefore offers
significant upside potential from the current share price of around 0.48p.